Dariohealth Stock News

DarioHealth (NASDAQ:DRIO) and Inari Medical (NASDAQ:NARI) are both medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their valuation, dividends, institutional ownership, profitability, analyst recommendations, earnings and risk. Earnings & Valuation This table compares DarioHealth and Inari Medicals gross revenue, earnings per share and valuation. []

Brokerages predict that DarioHealth Corp. (NASDAQ:DRIO) will report sales of $6.69 million for the current fiscal quarter, according to Zacks. Two analysts have made estimates for DarioHealths earnings. The highest sales estimate is $6.91 million and the lowest is $6.47 million. DarioHealth posted sales of $2.08 million in the same quarter last year, which suggests []

DarioHealth (NASDAQ:DRIO) and Liquidia (NASDAQ:LQDA) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their risk, valuation, earnings, dividends, institutional ownership, profitability and analyst recommendations. Analyst Ratings This is a summary of current ratings and price targets for DarioHealth and Liquidia, as []

Liquidia (NASDAQ:LQDA) and DarioHealth (NASDAQ:DRIO) are both small-cap medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their valuation, dividends, institutional ownership, risk, profitability, analyst recommendations and earnings. Valuation & Earnings This table compares Liquidia and DarioHealths top-line revenue, earnings per share (EPS) and valuation. [] The post Head-To-Head Contrast: Liquidia (NASDAQ:LQDA) & DarioHealth (NASDAQ:DRIO) appeared first on ETF Daily News .

Wall Street brokerages expect DarioHealth Corp. (NASDAQ:DRIO) to report sales of $6.69 million for the current quarter, Zacks reports. Two analysts have provided estimates for DarioHealths earnings. The lowest sales estimate is $6.47 million and the highest is $6.91 million. DarioHealth posted sales of $2.08 million during the same quarter last year, which would indicate []

Equities analysts predict that DarioHealth Corp. (NASDAQ:DRIO) will announce ($1.13) earnings per share for the current quarter, Zacks reports. Two analysts have issued estimates for DarioHealths earnings, with estimates ranging from ($1.31) to ($1.01). DarioHealth posted earnings of ($1.06) per share in the same quarter last year, which suggests a negative year over year growth []

After starting its B2B2C program last year, DarioHealth should finally start to see organic growth in revenues as the company starts to implement its solutions within a large health plan. The company

State Street Corp acquired a new stake in shares of DarioHealth Corp. (NASDAQ:DRIO) during the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund acquired 200,990 shares of the companys stock, valued at approximately $4,293,000. State Street Corp owned about 1.29% of DarioHealth as [] The post State Street Corp Acquires Shares of 200,990 DarioHealth Corp. (NASDAQ:DRIO) appeared first on ETF Daily News .

State Street Corp purchased a new position in DarioHealth Corp. (NASDAQ:DRIO) during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 200,990 shares of the companys stock, valued at approximately $4,293,000. State Street Corp owned about 1.29% of DarioHealth at the end of [] The post State Street Corp Invests $4.29 Million in DarioHealth Corp. (NASDAQ:DRIO) appeared first on ETF Daily News .

Nuveen Asset Management LLC bought a new position in DarioHealth Corp. (NASDAQ:DRIO) in the 2nd quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor bought 50,137 shares of the companys stock, valued at approximately $1,071,000. Nuveen Asset Management LLC owned approximately 0.32% of DarioHealth as of []

DarioHealth (NASDAQ:DRIO) issued its quarterly earnings results on Sunday. The company reported ($1.18) earnings per share (EPS) for the quarter, missing the Thomson Reuters consensus estimate of ($0.94) by ($0.24), MarketWatch Earnings reports. DarioHealth had a negative net margin of 377.14% and a negative return on equity of 66.69%. During the same period in the []

DarioHealth Corp. (DRIO) CEO Erez Raphael on Q3 2021 Results - Earnings Call Transcript